北京睿脉医药科技有限公司

Ray Medicine is a newco formed in January 2022, focusing on new cellulartherapy development that integrates biomolecules with living cells forthe treatment of cancer and metabolic diseases without geneticengineering and in vitro expansion of the cells. Ray Medicine’s uniquecell-based therapy in terms of ADME and pharmacology avoids geneintegration that conceals a great risk of tumorigenesis in the long termand does not need costly in vitro cell expansion and complicatedpreparation process like current cellular therapies (e.g. CAR-T).展开详情

Ray Medicine is a newco formed in January 2022, focusing on new cellulartherapy development that integrates biomolecules with living cells forthe treatment of cancer and metabolic diseases without geneticengineering and in vitro expansion of the cells. Ray Medicine’s uniquecell-based therapy in terms of ADME and pharmacology avoids geneintegration that conceals a great risk of tumorigenesis in the long termand does not need costly in vitro cell expansion and complicatedpreparation process like current cellular therapies (e.g. CAR-T).收起